TA
SUPN icon

Teachers Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Teachers Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.6M Buy
102,889
+2,831
+3% +$105K ﹤0.01% 1623
2018
Q4 		$3.32M Buy
100,058
+2,117
+2% +$91K ﹤0.01% 1543
2018
Q3 		$4.93M Buy
97,941
+2,352
+2% +$116K 0.01% 1461
2018
Q2 		$5.72M Buy
95,589
+8,076
+9% +$418K 0.01% 1354
2018
Q1 		$4.01M Sell
87,513
-202
-0.2% -$8.43K 0.01% 1439
2017
Q4 		$3.5M Sell
87,715
-26,938
-23% -$1.06M ﹤0.01% 1533
2017
Q3 		$4.59M Sell
114,653
-351,407
-75% -$15.2M 0.01% 1385
2017
Q2 		$20.1M Buy
466,060
+29,939
+7% +$1.07M 0.03% 674
2017
Q1 		$13.7M Buy
436,121
+7,861
+2% +$211K 0.02% 836
2016
Q4 		$10.8M Sell
428,260
-184,149
-30% -$4.11M 0.02% 922
2016
Q3 		$15.1M Buy
612,409
+8,132
+1% +$184K 0.03% 736
2016
Q2 		$12.3M Buy
604,277
+54,082
+10% +$959K 0.02% 778
2016
Q1 		$8.39M Buy
550,195
+46,100
+9% +$602K 0.02% 940
2015
Q4 		$6.78M Buy
504,095
+53,060
+12% +$821K 0.01% 1036
2015
Q3 		$6.33M Buy
451,035
+57,173
+15% +$1.06M 0.01% 1033
2015
Q2 		$6.69M Buy
393,862
+343,797
+687% +$4.89M 0.01% 1066
2015
Q1 		$605K Hold
50,065
– – ﹤0.01% 2325
2014
Q4 		$416K Hold
50,065
– – ﹤0.01% 2533
2014
Q3 		$435K Hold
50,065
– – ﹤0.01% 2478
2014
Q2 		$548K Buy
50,065
+27,053
+118% +$241K ﹤0.01% 2379
2014
Q1 		$206K Buy
23,012
+6,640
+41% +$61.2K ﹤0.01% 2861
2013
Q4 		$123K Hold
16,372
– – ﹤0.01% 2997
2013
Q3 		$120K Sell
16,372
-117
-0.7% -$786 ﹤0.01% 2976
2013
Q2 		$106K Buy
+16,489
New +$97.1K ﹤0.01% 2983

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Teachers Advisors's SUPN Position: Q1 2019 in Review

Teachers Advisors increased its Supernus Pharmaceuticals (SUPN) stake by 2.8% in Q1 2019, buying an estimated $105K and bringing the position to 102,889 shares worth $3.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

Teachers Advisors first reported a position in SUPN in Q2 2013 and has held it in 24 quarters since. The position peaked at $20.1M in Q2 2017. 289 funds tracked by Wall St. Rank hold SUPN as of Q1 2019.

  • Teachers Advisors held 102,889 shares of Supernus Pharmaceuticals worth $3.6M as of Q1 2019.
  • Teachers Advisors bought 2,831 Supernus Pharmaceuticals shares in Q1 2019, an estimated $105K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1623 holding.
  • Teachers Advisors first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Supernus Pharmaceuticals position peaked at $20.1M in Q2 2017.
  • 289 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.